In face of US 'threat,' how does Venezuela's military stack up?

TORONTO, ON / ACCESS Newswire / September 3, 2025 / Jaguar Mining Inc. ("Jaguar" or the "Company") (TSX:JAG) today announced the successful resolution of all outstanding legal matters related to the incident at the Satinoco dry-stacked pile at its MTL complex. The final settlement with the Public Prosecutor's Office in Brazil, together with previously concluded agreements, definitively addresses all known liabilities arising from the incident. This resolution represents an important milestone for the Company's financial stability and provides greater operational clarity.
BURLINGTON, ON / ACCESS Newswire / September 3, 2025 / Murchison Minerals Ltd. ("Murchison" or the "Company") (TSXV:MUR) is pleased to announce the appointment of Rylan Colwell to its Board of Directors.
SAN FRANCISCO, CA / ACCESS Newswire / September 3, 2025 / Portal to Bitcoin (PORTAL), a custodyless protocol bringing atomic swaps natively to Bitcoin and other blockchains, announced today that its native token, $PTB, will be listed on a number of the world's foremost cryptocurrency exchanges. The earned listings to this point are Binance Alpha & Futures, Kraken, KuCoin, Gate.io, Bitget, and MEXC, significantly escalating the accessibility and liquidity to token holders throughout the globe.
Second annual event spotlights natural product industry changemakers transforming the landscape and cultivating deep-rooted connections that drive sustainable transformation.
NEW YORK, NY / ACCESS Newswire / September 3, 2025 / When you need help eliminating high-interest debt and tackling multiple outstanding balances, a debt consolidation loan can be a very powerful tool. However, some people may worry that taking out another loan will negatively impact their credit score and worsen their situation. As with any credit, it comes down to your individual situation and how you manage your debt.
SAN CARLOS, CA / ACCESS Newswire / September 03, 2025 / Finances can deeply influence a couple's relationship, often shaping how they plan, communicate, and handle stress. When couples align on money matters, it can strengthen trust, teamwork, and long-term stability. There are many goals to consider-from short- and long-term priorities to family planning and health. This article explores key categories of financial goals for couples, along with specific savings goals they may want to focus on together.
GUELPH, ON / ACCESS Newswire / September 3, 2025 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSXV:ZEN) an intellectual property technology development and commercialization company, today announces that Ilse Treurnicht has resigned from the Board of Directors effective immediately. Ilse has agreed to serve on the Zentek Advisory Board and continue to support the Company.
MARION, NC / ACCESS Newswire / September 3, 2025 / Greene Concepts Inc. (OTCID:INKW), a publicly traded beverage and bottling company and the proud owner of the Be Water™ artesian spring water brand, today announced that its shares are now quoted on the OTCID Platform, formerly known as the OTC Pink Current marketplace. This advancement strengthens the Company's transparency, visibility, and accessibility for investors.
Corrects presentation date and spelling error
Rockefeller Center transforms into four-day golf experience; Official Watch Parties to be hosted across ManhattanClick here for photo renderings.
NEW YORK, NY / ACCESS Newswire / September 3, 2025 / Market inflection points are often hard to recognize until they've already revealed the winners. Carbon credits in the early 2000s. ESG reporting systems in the 2010s. Each began as a niche concept, often dismissed as a policy experiment or compliance burden. But once governments codified them into regulation, the companies at the forefront didn't just grow; they defined categories, captured billions in enterprise value, and rewrote the playbook for sustainability-linked markets.
Empowering Young Athletes with "Be Your Best" Technology to Enhance Player Development
Exousia Pro aims to develop three new subdivisions and launch new products during the 4th quarter.The market for our new products is currently valued at $8.7 billion, projected to grow to $18.5 billion over the next decade.
MESA, ARIZONA / ACCESS Newswire / September 3, 2025 / Medical Care Technologies Inc. (OTC PINK:MDCE) today announced its AI-powered Wound Monitoring System, designed to provide real-time wound care diagnostics using only smartphone imagery.
Landmark Federal Antitrust Case Seeks Significant Damages
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018, AS AMENDED. ON PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.
VANCOUVER, BRITISH COLUMBIA / ACCESS Newswire / September 3, 2025 / CoTec Holdings Corp. (TSXV:CTH)(OTCQB:CTHCF) ("CoTec" or the "Company"), retracts in its entirety, at the request of CIRO, the press release that was disseminated on September 2, 2025. CoTec also confirms that it did not pay for the research report.
SALT LAKE CITY, UT / ACCESS Newswire / September 3, 2025 / FatPipe, Inc. (NASDAQ:FATN) ("FatPipe" or the "Company"), a pioneer in enterprise-class, application-aware, secure software-defined wide area network ("SD-WAN") solutions that provide the highest levels of reliability, security, and optimization for Wide Area Networks (WANs), today announced that FatPipe CEO Dr. Ragula Bhaskar will present to institutional investors and stock analysts at the H.C. Wainwright 27th Annual Global Investment Conference in New York City on September 8-10, 2025.
HOUSTON, TX / ACCESS Newswire / September 3, 2025 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced that it will present at the H.C. Wainwright 27th Annual Global Investment Conference being held September 8-10, 2025 in New York, NY.
An exclusive call to visionary architects worldwide to create a transformative sanctuary immersed in nature
Firm achieves highest ranking to date, continuing steady climb on national list
New capabilities across PRISM, SPG9000, INSPECT, and ARGUS deliver precision monitoring for broadcast, IP, and OTT services: See it in action at IBC2025
Executive Brings More than 25+ Years of Experience to Financial Institution
$4.25 Million Sale Will Complete Company Divestiture of Non-Core Assets
Proactive Renewals leads new feature set aimed at helping agencies surface better coverage options during ongoing market pressure
Ambience's seamless integration with Epic's EHR improves patient experience, reduces burden for clinicians, and strengthens compliance for health system
Refreshed Brand Identity and Expanded Programming Reaching More than 17 Million Viewers is Building Momentum Among Both Viewers and Advertisers
SOUTH SAN FRANCISCO, CA / ACCESS Newswire / September 3, 2025 / CASI Pharmaceuticals, Inc. (NASDAQ:CASI), a clinical-stage biopharmaceutical company focused on developing innovative therapies for patients with organ transplant rejection and autoimmune diseases, today announced that David Cory, CEO, will present a company update at the H.C. Wainwright 27th Annual Global Investment Conference on September 8, 2025 at 10:00 AM ET.
NetBrands Corp appoints Nico Smid as a strategic advisor to help guide and strengthen the company's position in Bitcoin mining, digital asset treasury management, and industry competitiveness.
New high-margin, pure profit revenue stream for Nextech3D.ai.
American Robotics to showcase Iron Drone Raider at international INTERPOL Drone Incursion Countermeasure Exercise (IDICE) organized by UAS Norway in cooperation with INTERPOLParticipation highlights Ondas' leadership in advancing counter-UAS capabilities for global defense and homeland security markets
Aspire's sublingual aspirin formulation significantly inhibited serum thromboxane B2 (TxB2) within the first two minutes after dosingTxB2 is a biomarker indicating aspirin's effect on platelet aggregation, the clumping of platelets that leads to dangerous blood clotsThis rapid inhibition is critical during suspected heart attacks, when clots blocking heart arteries can cause permanent muscle damageLab results showed Aspire's product acted approximately twice as fast as the current recommendation for chewed aspirin tablet treatmentThese clinical trial results enable a potential regulatory submission for accelerated approval on track for Q3 2025